A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RR / relapse rate

[Related PubMed/MEDLINE]
Total Number of Papers: 105
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RR  (>> Co-occurring Abbreviation)
Long Form:   relapse rate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment. allo-SCT, cHL, CR, HID, MRD, NRM, PFS, PR, R/R, S/PD, URD
2020 Cladribine vs other drugs in MS: Merging randomized trial with real-life data. ARR, RCTs, RRMS
2020 Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis. allo-HSCT, auto-HSCT, CIs, CMR, CR, HRs, ORs, OS, RFS, TKIs, TRM
2020 Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy. DFS, FLU/MEL, NRM, oral, OS
2020 Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis. aGVHD, cGVHD, CI, Haplo-SCT, NRM, ORs, OS, PFS, UCBT
2020 Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis. aGVHD, cGVHD, CI, Haplo-SCT, MSD, MUD-SCT, NRM, OR, OS, PFS
2020 Impacts of water temperature on phosphorus release of sediments under flowing overlying water. ECTP
2020 Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell transplantation. aGVHD, CR, DFS, HCT-CI, MDS, MSD-PBSCT, NRM, OS, PCT
2020 The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. CI, HCT, HR, OS
10  2020 [Outcomes of 138 myelodysplastic syndrome patients with HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation]. aGVHD, DFS, HCT-CI, HMA, IPSS-R, MDS, MDS-EB2, MSD-PBSCT, NRM, OS
11  2019 Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis. allo-SCT, AML, auto-SCT, FLT3-ITD, MSD, MUD, OS, PRT, RFS, TRM
12  2019 Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety-A Systematic Review with Meta-Analysis. CAR-T, CRR, CSER, ORR
13  2019 Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study. APOE, DO, EDSS, LDL, MS, MSSS, OC, RRMS
14  2019 The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review. CTC
15  2019 Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer. ALNC, YWBC
16  2018 Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017. allo-SCT, GVHD, MM, OS, TRM
17  2018 Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation. aGvHD, aKIR, allo-HSCT, cGVHD, DFS, GVHD, GVL, HR, iKIR, KIR, NK cell, OR, OS
18  2018 Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. AML, NRM, OS, RFS
19  2018 Removal of ciprofloxacin from aqueous solutions by ionic surfactant-modified carbon nanotubes. CIP, CNTs, CTAB, SDS
20  2018 [Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation]. aGVHD, allo-PBSCT, cGVHD, DC, DFS, FDC, OS, PCR-STR
21  2017 Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group. AML, CNS, DFS, EFS, EOI, i.t, OS, WBC
22  2017 Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review. ACH, CI, CR, EEC, IUD, PR
23  2017 High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission. allo-SCT, AML, cCR, DFS, HR, MRD, OS
24  2017 Maintenance phase in psoralen-ultraviolet A phototherapy of early-stage mycosis fungoides. Acritically appraised topic. CAT, CR, MF, PUVA, RCTs, USCLC, UVL
25  2017 Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia. B-ALL, EFS, HR, OS
26  2017 PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia. AML, DFS, OS, PIM-1
27  2017 Prognostic Parameters of Acute Myeloid Leukaemia at Presentation. AML, CR, HDT/SCT, OS, RFS
28  2017 [Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]. allo-HSCT, AML, cGVHD, DFS, GVHD, OS, TRM
29  2017 [Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation with IBu Precondition Regimen in Treatment for 11 Patients with Low to Intermediate Risk Acute Myeloid Leukemia]. AML, auto-PBHSCT, BU, CR, DFS, IDA, OS, TRM
30  2017 [The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]. APL, CR, DFS, OS
31  2016 Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group. AML, CR, DFS, GO, GO, HCT, ITD-AR, TRM
32  2016 Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma. FDG, HL, NRM, OS, PFS, SCT
33  2016 Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. allo-SCT, EFS, HL, NRM, RIC
34  2016 Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma. CR, DR, NK, OS, PFS, SCRT
35  2016 The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. IVIGs, MS, PRIMS
36  2016 The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease. FLAG
37  2016 Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). CSI, HR, SWENOTECA
38  2015 A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies. allo-HSCT, Flu, GVHD, HSCT, TRM
39  2015 Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies. allo-HSCT, AML, CI, HR, HSCT, OS, RFS, TRM
40  2015 Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT). ALWP, EBMT, GVHD, LFS, MAC, MK AML, NRM, OS, RIC, SCT
41  2015 Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis. AML, CIs, CRR, DFS, HRs, OR, OS
42  2015 Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes. CI, CS, CT, MA, RT
43  2015 [Analysis of prognosis in acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation]. allo-HSCT, AML, IFD, OS
44  2015 [Comparison of outcomes of adult acute lymphoblastic leukemia patients underwent autologous and allogeneic hematopoietic stem cell transplantation]. ALL, allo-HSCT, auto-HSCT, MRD, OS
45  2014 Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group. AML, ITD, OS
46  2014 Community based interventions for the prevention and control of tuberculosis. CBI, CHW, HIV, TB
47  2014 FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia. AML, BCRP, DFS, FLT3-ITD, LRP, MLL-PTD, mRNA, MRP-1
48  2014 Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma. allo-HCT, DLBCL, NRM, OS, PS, sib, URD
49  2014 Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey. BMI, HRQoL, MS, PA, PwMS
50  2014 Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children. CMV, GVL, HSCT, PCR
51  2014 [Effect of autologous peripheral blood stem cell transplantation in 13 patients with AML1/ETO (+) acute myeloid leukemia]. APBSCT, LFS, OS
52  2014 [Impact of graft versus host disease on outcome of allogeneic peripherial blood stem cell transplantation for leukemia]. allo-PBSCT, DFS, GVHD, OS, TRM
53  2014 [Outcome and prognosis in acute myeloid leukemia patients treated with related peripheral blood hematopoietic stem cell transplantation]. LFS, OS, PBHSCT
54  2014 [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome]. aGVHD, allo-HSCT, AML, BU, cGVHD, CY, DFS, Flu, G-CSF, HLA, IPSS, MDS, NRM, OS, RA, RAEB, RAEB-t
55  2013 The superiority of allogeneic hematopoietic stem cell transplantation from unrelated donor over chemotherapy for adult patients with high-risk acute lymphoblastic leukemia in first remission. ALL, allo-HSCT, ATG, CR, LFS, MSD, NRM, URD
56  2013 Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation. HSCT, NRM, OS
57  2013 [Autologous stem cell transplantation for adult patients with acute lymphoblastic leukemia and related prognostic factors]. ALL, ASCT, LFS, WBC
58  2013 [Outcomes of younger than 60 years old adults with Ph/BCR-ABL positive acute lymphoblastic leukemia: a single center clinical trial of BDH ALL 2000/02]. allo-HSCT, ASCT, CR1, DFS, IM, MCR, OS
59  2013 [Prognostic significance of EBMT score system for hematological malignancies with allogeneic hematopoietic stem cell transplantation]. allo-HSCT, OS, TRM
60  2012 Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype. DFS, ERCC1, NSCLC
61  2012 Effect of release rate of the SF(6) tracer on methane emission estimates based on ruminal and breath gas samples. ---
62  2012 Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT. LFS, RIC
63  2012 Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. ARR, DMTs, EBF, GLAT, IFN-beta, MS, NBF, nEBF
64  2012 [Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]. allo-HSCT, OS, TRM
65  2012 [The correlation between early lymphocyte count post-allogeneic hematopoietic stem cell transplantation and prognosis in leukemia patients]. aGVHD, allo-HSCT, cGVHD, NRM, OS
66  2011 Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. allo-SCT, ASCT, DLBCL, NRM, OS, PFS, RIC
67  2011 Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. ALL, allo-HSCT, BU, CY, GVHD, TRM, VOD
68  2011 The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis. BSBMT, EBMT, MM, NRM, TTNT
69  2011 [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation]. aGVHD, allo-HSCT, AML, CML, DFS, OS, TRM
70  2011 [Relationship between early lymphocyte recovery and prognosis after allogeneic hematopoietic stem cell transplantation for acute leukemia in remission]. LC30, NRM, OS, SCT
71  2011 [The effect of inhibitory and activating natural killer cell immunoglobulin receptor on haplo-identical hematopoietic stem cell transplantation]. aGVHD, HSCT, MM, OS
72  2010 Adjuvant platinum-based chemotherapy in patients with epithelial ovarian cancer: prognostic factors and final outcome. CT, OS, OvCa, PFS, PL
73  2010 High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group. AML, DFS, HR, MFI, VLA-4
74  2010 Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies. aGVHD, cGVHD, Flu, NRM, OS, SCT
75  2010 Tailoring treatment duration to 12 to 16 weeks in hepatitis C genotype 2 or 3 with rapid virologic response: systematic review and meta-analysis of randomized controlled trials. ETR, GT, RBV, RVR, SVR
76  2010 The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin. allo-PBSC, NRM, RIC
77  2009 Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. AITL, allo-SCT, cGVHD, NRM, OS, PFS
78  2009 Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study. aGVHD, cGVHD, CsA, EFS, GVHD, HSCT, TRM, UD
79  2009 Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. ARR, ART, MS
80  2009 Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. MRI, MS, NMO, PI
81  2008 Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score. APOE, EDSS, MS, MSSS, PI
82  2008 Indications and results of cord blood transplant in children with leukemia. EBMT, UCBT
83  2008 Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. allo-SCT, GVHD, HL, HR, NRM, OS, PFS, RIC
84  2008 Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group. AML, DFS, DS, ITD, MLL, OS
85  2008 [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up]. allo-HSCT, auto-HSCT, DFS, TRM
86  2007 Management of acute myeloid leukaemia--5 years experience at Armed Forces Bone Marrow Transplant Centre, Rawalpindi. AML, ATRA, CR
87  2007 Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation. AML, CR, DFS, MA, MDS, non-MA
88  2007 Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. EDSS, IFN-beta, MS, QUASIMS, s.c
89  2007 Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. EBMT, EFS, OS
90  2006 Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. ALL, CI, MRD, PCR, SR
91  2006 Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study. AML, BM, BSBMT, NRM, OS, PBSCs, PFS, TBI
92  2006 XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. AML
93  2004 Interferon alpha as adjuvant postsurgical treatment of melanoma: a meta-analysis. IFN-alpha, OS
94  2003 [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia]. ABMT, APBSCT, DFS, TRM
95  2002 High-dose intravenous immunoglobulin treatment of multiple sclerosis. ---
96  2002 Variation in murid Plasmodium desequestration and its modulation by stress and pentoxifylline. OT, POF
97  2000 Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. BMT, Cs-A1, CsA, GVHD
98  2000 Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia? GVHD
99  1999 Autologous peripheral blood stem cell transplantation for acute leukaemias. ABMT, ABSCT, AML, DFS, PBSC
100  1998 Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group. CSA, CsA1, EFS, TRM